These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
74. [Evaluation of the effect and tolerance of topical dermatologic agents]. Bielický T Cesk Dermatol; 1966 Aug; 41(4):248-50. PubMed ID: 5975165 [No Abstract] [Full Text] [Related]
75. Drug interactions: perspectives of the Canadian Drugs Directorate. Jurima-Romet M Adv Pharmacol; 1997; 43():239-54. PubMed ID: 9342180 [No Abstract] [Full Text] [Related]
76. [A contribution to the discussion on the definition of dosage forms for dermatologic drugs]. Brandau R Z Hautkr; 1977 Aug; 52(16):853-8. PubMed ID: 899121 [No Abstract] [Full Text] [Related]
77. [Use of drugs in aerosol containers]. Lifanov NI; Kupriianov VA Med Sestra; 1981 Jul; 40(7):53-4. PubMed ID: 6911425 [No Abstract] [Full Text] [Related]
78. Compounding facility for dermatologic topical medications: a prototype for rural areas of developing countries. Maddin S; Ryan T; Kopf AW; Grossman H; Strauss J Int J Dermatol; 1996 Jan; 35(1):63-4. PubMed ID: 8838934 [No Abstract] [Full Text] [Related]